Holta Invest is owned by Kjetil Holta who is actively involved as the company's chairman.

Board of directors

Holta Invest is owned by Kjetil Holta who is actively involved as the company's chairman. The Board also comprises external independent members who represent a significant experience in industry and finance.

Kjetil Holta (1965), Chairman

Kjetil holds a MSc of Business and Economics from Norwegian Business School (BI), and has previously worked as investment director for Høegh Capital Partners. Kjetil has served on several boards including Tinfos AS and Tennant Insurance Group AB. Tinfos was sold to French metallurgical group Eramet and Tennant was sold to Gjensidige Forsikring. He is currently head of IC Spear Capital.

Bjørn Flatgård (1949), Deputy Chair

Bjørn Flatgård runs his own business, the principal activities of which are participation on board of directors and investing. Mr. Flatgård is a graduate from the Norwegian University of Science and Technology and from the Norwegian Business School. His previous experience includes top management positions such as CEO of Elopak and of Nycomed Pharma. He has also been part of the executive management of Hafslund Nycomed. He currently serves among others on the board of Aker ASA and Aker Biomarine ASA, as well as chairman of the board of Handelsbanken Norge and Salmar ASA.

Jonas Arlebäck (1970)

Jonas was CFO of Handicare Group AB until 2016 and worked with special projects, e g IPO-preparation, in the company during 2017. He started his career as a management consultant. At first in McKinsey and later, as Partner, for Accenture. During his career he has gained experience about developing companies in terms of growth, performance, and capital injection. He has worked across the world – primarily in Europe. His specialties are value focused change – from short term turnarounds to long term strategic change.

Tomas Settevik (1960)

Tomas has his MSc of Business and Economics from Copenhagen Handelshøjskole. He has held several board memberships in Norway and in UK. He is currently working as an independent investor and advisor. His previous position was with Stokke AS which was divested to Koran PE company in 2015. He has had responsibility for global strategy, expansion strategies and sale of companies such as Stokke and Pronova BioPharma ASA (2008) where he served as CFO.